Borregaard (WKN: A1J5TM)
Seite 1 von 1 Neuester Beitrag: 02.02.23 18:23 | ||||
| Eröffnet am: | 20.09.17 18:45 | von: Tamakoschy | Anzahl Beiträge: | 7 |
| Neuester Beitrag: | 02.02.23 18:23 | von: Tamakoschy | Leser gesamt: | 5.553 |
| Forum: | Börse | Leser heute: | 3 | |
| Bewertet mit: |  | |||
Borregaard has one of the world's most advanced and sustainable biorefineries.
By using natural, sustainable raw materials, Borregaard produces advanced and environmentally friendly biochemicals that can replace oil-based products. Borregaard also holds strong positions within ingredients and fine chemicals.
Borregaard employes 1010 man-years in plants and sales offices in 16 countries throughout Europe, Americas, Asia and Africa.
Health, safety and environment
Health, safety and environment are integrated into Borregaard's business plan. The company aims to show social responsibility and work actively with initiatives that can contribute to sound environmental and social development.
Research and development
In line with Borregaard's strategy for specialisation and increased value creation, the company invests considerable resources in research and development. This is carried out at research centres in Norway, Spain, South Africa and the USA, as well as through extensive collaboration with customers, universities and research institutions in several countries.
http://www.borregaard.com/About-us
http://www.borregaard.com/Investor-Relations
http://de.4-traders.com/BORREGAARD-ASA-11751909/...&mots=Borregaa
https://de.marketscreener.com/BORREGAARD-ASA-11751909/unternehmen/
Borregaard ASA ist ein in Norwegen ansässiges Unternehmen, das sich mit dem Betrieb von Bio-Raffinerien beschäftigt. Sie produziert Biochemikalien und Biomaterialien, die ölbasierte Produkte ersetzen können. Borregaard ist in vier Abteilungen gegliedert: Borregaard ChemCell (Specialty Cellulose) ist verantwortlich für Spezialcellulose und Bioethanol; Borregaard LignoTech (Performance Chemicals) ist verantwortlich für Produkte auf Ligninbasis und Handelsaktivitäten; Borregaard Synthesis ist verantwortlich für Feinchemikalien und Arzneimittel; Borregaard Ingredients ist verantwortlich für Vanillinprodukte für Lebensmittel. Darüber hinaus investiert die Gesellschaft in Forschungs- und Entwicklungsaktivitäten, die in Forschungszentren in Norwegen, Spanien, Südafrika und den USA durchgeführt werden. Zum 31. Dezember 2013 besaß die Gesellschaft eine direkte hundertprozentige Tochtergesellschaft, die Borregaard AS, und betrieb Fabriken und Vertriebsbüros in 16 Ländern in Europa, Nord- und Südamerika, Asien und Afrika.
Borregaard ASA meldet Ergebnis für das erste Quartal bis zum 31. März 2022
03.05.2022 | 10:06
Borregaard ASA gab die Ergebnisse für das erste Quartal zum 31. März 2022 bekannt. Für das erste Quartal meldete das Unternehmen einen Umsatz von 1.615 Millionen NOK im Vergleich zu 1.419 Millionen NOK vor einem Jahr. Der Nettogewinn belief sich auf 217 Millionen NOK im Vergleich zu 146 Millionen NOK vor einem Jahr. Der unverwässerte Gewinn pro Aktie aus dem fortgeführten Geschäft betrug 2,18 NOK gegenüber 1,47 NOK vor einem Jahr. Der verwässerte Gewinn pro Aktie aus dem fortgeführten Geschäft betrug 2,17 NOK gegenüber 1,46 NOK vor einem Jahr.
Borregaard ASA: EBITDA1 of NOK 364 million in the 4th quarter
Borregaard's operating revenues reached NOK 1,770 million (NOK 1,446 million)2 in the 4th quarter of 2022. EBITDA1 increased to NOK 364 million (NOK 263 million). BioMaterials and Fine Chemicals had significant result improvements while BioSolutions had a decrease. The net currency impact on EBITDA1 was positive compared with the 4th quarter of 2021.
Increased sales prices in addition to a higher volume and a favourable product mix were the main reasons for the EBITDA1 improvement in BioMaterials. The result improvement in Fine Chemicals was due to increased sales prices and a higher bioethanol sales volume. Reduced margin and volume for traded vanillin products were the main reasons for the EBITDA1 decrease in BioSolutions. Cost increases affected all business areas.
Operating profit reached NOK 228 million (NOK 156 million). Net financial items were NOK -18 million (NOK -24 million). Profit before tax was NOK 210 million (NOK 132 million). Earnings per share were NOK 1.85 (NOK 1.02).
Borregaard will invest NOK 230 million to reduce CO2 emissions and increase energy flexibility at the biorefinery in Norway. This investment will allow for a 30,000 tonnes annual reduction of CO2 emissions by replacing liquified natural gas (LNG) with electricity and by improved energy efficiency. In addition, there is a significant cost reduction potential by removing absolute dependency on LNG and introducing more options to switch between alternative energy sources.
Full year 2022
Operating revenues increased to NOK 6,881 million (NOK 5,805 million). EBITDA1 increased to an all-time high of NOK 1,643 million (NOK 1,372 million). Profit before tax was NOK 1,118 million (NOK 873 million). Earnings per share were NOK 8.95 (NOK 6.95).
- We are pleased with the strong performance and improved results in all business areas in 2022. Borregaard's specialisation strategy and diversified market positions, have proven its resilience in the face of significant cost inflation, says President and CEO Per A. Sørlie.